Back to top
more

Meridian Bioscience Inc. (VIVO)

(Delayed Data from NSDQ)

$11.51 USD

11.51
1,168,817

-0.48 (-4.00%)

Updated May 3, 2019 04:00 PM ET

After-Market: $11.50 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

The Zacks Analyst Blog Highlights: Ryerson Holding, Schnitzer Steel, Scholastic, P.A.M. Transportation Services and Meridian Bioscience

The Zacks Analyst Blog Highlights: Ryerson Holding, Schnitzer Steel, Scholastic, P.A.M. Transportation Services and Meridian Bioscience

Zacks.com featured highlights include: Bonanza Creek Energy, Meridian Bioscience, Ameris and Lakeland Industries

Zacks.com featured highlights include: Bonanza Creek Energy, Meridian Bioscience, Ameris and Lakeland Industries

Kevin Cook headshot

Bull of the Day: Meridian Bioscience (VIVO)

Small-cap diagnostics player will grow sales 20%+ to over $310 million on COVID-19 testing and its mutations

Zacks.com featured highlights include: Bellicum Pharmaceuticals, Prometic Life Sciences, Vaccinex, Meridian Bioscience and 360 DigiTech

Zacks.com featured highlights include: Bellicum Pharmaceuticals, Prometic Life Sciences, Vaccinex, Meridian Bioscience and 360 DigiTech

Nitish Marwah headshot

4 Stocks With High Net Income Ratio to Scoop Up

Investors always look for companies with a high level of profitability regardless of the ongoing market condition.

Nalak Das headshot

5 Top-Ranked Small Hidden Gems With Strong Upside in 2021

We have narrowed down our search to five small cap stocks that have strong growth potential for 2021. These are: SCHL, SCHN, RYI, PTSI, VIVO.

Sanghamitra Saha headshot

Bet on Rising P/E With These 5 Top-Ranked Stocks

Want to try some out-of-the-box approach? Tap five stocks with increasing P/E ratios.

Can Meridian Bioscience (VIVO) Run Higher on Rising Earnings Estimates?

Meridian Bioscience (VIVO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Is Meridian Bioscience (VIVO) Outperforming Other Medical Stocks This Year?

Is (VIVO) Outperforming Other Medical Stocks This Year?

Panel Of Zacks Experts headshot

Top Stock Picks for Week of December 28, 2020

Two Stocks With an Upward Moving Earnings Outlook.

Zacks.com featured highlights include: LAKE, VNW, VIVO, CSV and WYY

Zacks.com featured highlights include: LAKE, VNW, VIVO, CSV and WYY

Anirudha Bhagat headshot

6 Top-Rated Stocks With Solid Net Profit Margin

Here are six best-performing stocks with substantial net profit margins that can contribute toward making an enriching portfolio.

Zacks.com featured highlights include: Meridian Bioscience, Piper Sandler, Herc Holdings, Aviat Networks and Carriage Services

Zacks.com featured highlights include: Meridian Bioscience, Piper Sandler, Herc Holdings, Aviat Networks and Carriage Services

Anirudha Bhagat headshot

6 Top-Rated Stocks to Bet On With Solid Net Profit Margins

Let's take a look at these six top-ranked stocks with impressive net profit margins for a winning portfolio.

Is Meridian Bioscience (VIVO) Stock Outpacing Its Medical Peers This Year?

Is (VIVO) Outperforming Other Medical Stocks This Year?

Why Meridian Bioscience (VIVO) Might be Well Poised for a Surge

Meridian Bioscience (VIVO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks.com featured highlights include: Vista Outdoor, Meridian Bioscience, Standard Motor Products, NIC and Azure Power

Zacks.com featured highlights include: Vista Outdoor, Meridian Bioscience, Standard Motor Products, NIC and Azure Power

Nilanjan Banerjee headshot

Sail Through the Choppy Market With These 5 Low-Beta Stocks

To combat the choppy market conditions, it is of utmost importance to create a portfolio of low-beta stocks.

New Strong Buy Stocks For November 18th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Has Meridian Bioscience (VIVO) Outpaced Other Medical Stocks This Year?

Is (VIVO) Outperforming Other Medical Stocks This Year?

Meridian Bioscience (VIVO) Q4 Earnings and Revenues Top Estimates

Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 35.71% and 7.88%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Meridian Bioscience (VIVO) Earnings Expected to Grow: Should You Buy?

Meridian Bioscience (VIVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Owens & Minor (OMI) Catches Eye: Stock Jumps 8.3%

Owens & Minor (OMI) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Meridian Bioscience (VIVO) Beats Q3 Earnings and Revenue Estimates

Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 129.17% and 28.26%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Trina Mukherjee headshot

What's in Store for Meridian Bioscience's (VIVO) Q3 Earnings?

Meridian Bioscience's (VIVO) fiscal third-quarter results are likely to reflect strong performance by Life Science business line.